Mendelian randomization studies using GWAS methodology have confirmed the association of PAD with hemostatic factors, i.e., genetically increased factor VIII activationand von Willebrand factor concentration [93], and with altered lipoprotein metabolism i.e., genetically determined extra-small very low density lipoproteins [94]. This evidence concerns the gene VWF and peripheral arterial disease.